argenx SE (ARGX) Stock Forecast

NASDAQ: ARGXAnalyst ratings, price target and estimates.

ARGX analyst forecast

as of October 17, 2026
Analyst consensus
Buy
4.48 / 5 from 25 analysts
Price target
$1,152.91
average of analyst targets
Upside to target
+40.7%
from the latest close
Next earnings
October 22, 2026
EPS estimate $7.44
52-week range
$663.93 – $1,058.90

ARGX analyst ratings

25 analysts
Strong buy
1560%
Buy
728%
Hold
312%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

ARGX price target

Price $819.14Target $1,152.91
52-week low $663.9352-week high $1,058.90

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

ARGX earnings per share estimates

argenx SE EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$27.83−$27.83−$27.83$5.18−637.3%1
Current fiscal year (2026)$18.68−$5.36$28.07$19.57−4.6%4
Next fiscal year (2027)$35.59$32.19$40.61$18.68+90.5%3

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

ARGX revenue estimates

argenx SE revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$1.64B$1.63B$1.64B+42.1%2
Current fiscal year (2026)$6.30B$6.20B$6.38B+48.4%4
Next fiscal year (2027)$7.77B$7.65B$8.02B+23.2%4

ARGX EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

ARGX revenue: reported and forecast

Reported revenueEstimate (average; low–high)

ARGX EPS estimate revisions

argenx SE EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$6.94$7.33−$27.83−$27.83−$27.83−500.9%0 up · 0 down
Current fiscal year (2026)$26.08$28.00$18.36$18.68$18.68−28.4%1 up · 1 down
Next fiscal year (2027)$37.19$38.21$34.72$34.72$35.59−4.3%2 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

ARGX earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; ARGX beat in 10 of 12.

What analysts expect from ARGX

25 analysts cover argenx; their consensus rating is buy (4.48 on a 1–5 scale, where 5 is a strong buy). The average price target is $1,152.91, 40.7% above the latest close of $819.14. Analysts expect earnings of $18.68 per share for 2026, −4.6% from a year earlier. For 2027 the average estimate is $35.59 per share on revenue of $7.8 billion. argenx beat the EPS estimate in 10 of the last 12 quarters.

Related: ARGX income statement, ARGX key metrics, ARGX chart. See the ARGX stock overview for the latest quote and news.

ARGX forecast FAQ

What is argenx's price target?

The average analyst price target for argenx is $1,152.91, 40.7% above the latest close of $819.14.

Is argenx a buy, hold or sell?

Of 25 analysts covering argenx, 15 rate it a strong buy, 7 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is argenx's EPS forecast?

Analysts forecast $18.68 per share for 2026 (range −$5.36 to $28.07); for 2027 the estimate is $35.59.

What is argenx's revenue forecast?

The average revenue estimate for 2026 is $6.3 billion, growth of 48.4%; for 2027 it is $7.8 billion.

When does argenx report earnings?

argenx is expected to report results for the quarter ending September 30, 2026 on October 22, 2026 before the market opens; the EPS estimate is $7.44.

Does argenx usually beat earnings estimates?

argenx reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Biotechnology: forecast